Terms: = Breast cancer AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7 AND Staging
19 results:
1. Triple-negative breast cancer survival prediction using artificial intelligence through integrated analysis of tertiary lymphoid structures and tumor budding.
Hou X; Li X; Han Y; Xu H; Xie Y; Zhou T; Xue T; Qian X; Li J; Wang HC; Yan J; Guo X; Liu Y; Liu J
Cancer; 2024 Apr; 130(S8):1499-1512. PubMed ID: 38422056
[TBL] [Abstract] [Full Text] [Related]
2. Clinicopathologic Features and Immune Cell Subtypes Analysis of Tumor-infiltrating Lymphocytes Rich Invasive breast Carcinoma of No Special Type.
Zhao Y; Huang T; Jin X; Gong XM; Lu YZ
Appl Immunohistochem Mol Morphol; 2023 Jul; 31(6):354-362. PubMed ID: 37278279
[TBL] [Abstract] [Full Text] [Related]
3. Initial Evaluation of [
Watabe T; Naka S; Tatsumi M; Kamiya T; Kimura T; Shintani Y; Abe K; Miyake T; Shimazu K; Kobayashi S; Kurokawa Y; Eguchi H; Doki Y; Inohara H; Kato H; Mori Y; Cardinale J; Giesel FL
J Nucl Med; 2023 Aug; 64(8):1225-1231. PubMed ID: 37268427
[TBL] [Abstract] [Full Text] [Related]
4. [Expression of HMGB1 protein in breast cancer and its clinicopathological significance].
Wang CQ; Huang BF; Wang Y; Hu GR; Wang Q; Shao JK
Zhonghua Bing Li Xue Za Zhi; 2020 Jan; 49(1):57-61. PubMed ID: 31914536
[No Abstract] [Full Text] [Related]
5. mRNA Expression of
Gera R; Mokbel L; Jiang WG; Mokbel K
Cancer Genomics Proteomics; 2018; 15(6):447-452. PubMed ID: 30343278
[TBL] [Abstract] [Full Text] [Related]
6. [Prognosis and risk factors of 1 791 patients with breast cancer treated with breast-conserving surgery based on real-world data].
Chen SY; Tang Y; Song YW; Wang SL; Jin J; Liu YP; Wang WH; Fang H; Ren H; Sun GY; Wang JY; Jing H; Zhang JH; Liu XF; Yu ZH; Li YX
Zhonghua Zhong Liu Za Zhi; 2018 Aug; 40(8):619-625. PubMed ID: 30139034
[No Abstract] [Full Text] [Related]
7. Prevalence of biological types of breast cancer and their influence on disease staging and therapeutic management - a single-center study.
Nowikiewicz T; Chmielowska E; Andrusewicz H; Łysik-Miśkurka J; Głowacka I; Sowa M; Zegarski W
Pol J Pathol; 2017; 68(1):16-25. PubMed ID: 28547976
[TBL] [Abstract] [Full Text] [Related]
8. Internal Mammary Sentinel Lymph Node Biopsy With Modified Injection Technique: High Visualization Rate and Accurate staging.
Qiu PF; Cong BB; Zhao RR; Yang GR; Liu YB; Chen P; Wang YS
Medicine (Baltimore); 2015 Oct; 94(41):e1790. PubMed ID: 26469922
[TBL] [Abstract] [Full Text] [Related]
9. Plasmablastic lymphoma of the oral cavity with breast recurrence: a case report.
Samoon Z; Idrees R; Masood N; Ansari TZ
BMC Res Notes; 2015 May; 8():180. PubMed ID: 25933603
[TBL] [Abstract] [Full Text] [Related]
10. Primary malignant melanoma of the breast: case report and review of the literature.
Drueppel D; Schultheis B; Solass W; Ergonenc H; Tempfer CB
Anticancer Res; 2015 Mar; 35(3):1709-13. PubMed ID: 25750332
[TBL] [Abstract] [Full Text] [Related]
11. Primary breast lymphoma: a single-institute experience in Taiwan.
Ou CW; Shih LY; Wang PN; Chang H; Kuo MC; Tang TC; Wu JH; Lin TL; Hung YS; Dunn P
Biomed J; 2014; 37(5):321-5. PubMed ID: 25179707
[TBL] [Abstract] [Full Text] [Related]
12. [Primary lymphoma of breast: a clinicopathologic and prognostic study of 40 cases].
Yang H; Lang RG; Liu FF; Wang XF; Jin ZJ; Lü AJ; Wang Y; Fu XL; Fu L
Zhonghua Bing Li Xue Za Zhi; 2011 Feb; 40(2):79-84. PubMed ID: 21426801
[TBL] [Abstract] [Full Text] [Related]
13. [Primary lymphoma of breast: a clinicopathologic, immunophenotypic and prognostic study of 21 cases].
Wang XQ; Zhang LX; Bi CF; Luo TY; Lin L; Min M; Zhao Y; He GX; Feng J; Liu WP
Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):302-7. PubMed ID: 20654152
[TBL] [Abstract] [Full Text] [Related]
14. Leptomeningeal metastasis.
Chamberlain MC
Semin Neurol; 2010 Jul; 30(3):236-44. PubMed ID: 20577930
[TBL] [Abstract] [Full Text] [Related]
15. Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors.
Zlobec I; Lugli A
World J Gastroenterol; 2009 Dec; 15(47):5898-906. PubMed ID: 20014453
[TBL] [Abstract] [Full Text] [Related]
16. Primary bilateral ovarian and uterine Burkitt's lymphoma following chemotherapy for breast cancer.
Hatami M; Whitney K; Goldberg GL
Arch Gynecol Obstet; 2010 Apr; 281(4):697-702. PubMed ID: 19756677
[TBL] [Abstract] [Full Text] [Related]
17. Lymphoma of the breast. A clinicopathologic study of primary and secondary cases.
Topalovski M; Crisan D; Mattson JC
Arch Pathol Lab Med; 1999 Dec; 123(12):1208-18. PubMed ID: 10583925
[TBL] [Abstract] [Full Text] [Related]
18. KAI1, a putative marker for metastatic potential in human breast cancer.
Yang X; Welch DR; Phillips KK; Weissman BE; Wei LL
Cancer Lett; 1997 Nov; 119(2):149-55. PubMed ID: 9570365
[TBL] [Abstract] [Full Text] [Related]
19. Dukes' classification revisited. Findings from the National Surgical Adjuvant breast and Bowel Projects (Protocol R-01).
Fisher ER; Sass R; Palekar A; Fisher B; Wolmark N
Cancer; 1989 Dec; 64(11):2354-60. PubMed ID: 2804927
[TBL] [Abstract] [Full Text] [Related]
